Home > Balance Sheet > NATH BIOGENES (INDIA)

NATH BIOGENES (INDIA)
Total Current Liabilities

    Back to Balance Sheet
NATH BIOGENES (INDIA) is part of below Screeners ↓
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for NATH BIOGENES (INDIA)
Please provide your vote to see the results

NATH BIOGENES (INDIA) Last 5 Year Total Current Liabilities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2013
Total Current Liabilities ₹365 Cr₹262 Cr₹216 Cr₹194 Cr₹98 Cr

What is the latest Total Current Liabilities ratio of NATH BIOGENES (INDIA) ?

The latest Total Current Liabilities ratio of NATH BIOGENES (INDIA) is ₹365 Cr based on Mar2025 Consolidated results.
Year Total Current Liabilities
Mar2025₹365 Cr
Mar2024₹262 Cr
Mar2023₹216 Cr
Mar2022₹194 Cr
Mar2013₹98 Cr

How is Total Current Liabilities of NATH BIOGENES (INDIA) Trending?

Years Total Current Liabilities % Change
Mar2025 ₹365 Cr
39.19
Mar2024 ₹262 Cr
21.26
Mar2023 ₹216 Cr
11.40
Mar2022 ₹194 Cr
98.02
Mar2013 ₹98 Cr -

Compare Total Current Liabilities of peers of NATH BIOGENES (INDIA)

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NATH BIOGENES (INDIA) ₹329.3 Cr 1.1% -8.5% -8.7% Stock Analytics
KAVERI SEED COMPANY ₹4,398.6 Cr -5.4% -12.2% -42.8% Stock Analytics
VENKYS (INDIA) ₹2,034.1 Cr -3.5% -8.5% -9.3% Stock Analytics
AVT NATURAL PRODUCTS ₹1,066.6 Cr 1.8% 0.8% 7.5% Stock Analytics
BOMBAY SUPER HYBRID SEEDS ₹1,002.2 Cr -1.3% NA NA Stock Analytics
MANGALAM GLOBAL ENTERPRISE ₹497.0 Cr 6.6% 7.2% 21.2% Stock Analytics


NATH BIOGENES (INDIA) Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
NATH BIOGENES (INDIA)

1.1%

-8.5%

-8.7%

SENSEX

-2.2%

-3.3%

-8.8%


You may also like the below Video Courses